Evidence map›Paper›PMID 17088354›Full record

ArticleInfection and immunity2007

Proteome and antigen profiling of Coxiella burnetii developmental forms.

Sherry A Coleman, Elizabeth R Fischer, Diane C Cockrell, Daniel E Voth, Dale Howe, David J Mead, James E Samuel, Robert A Heinzen

Abstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Virulence · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Detection ofJournal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Virulence · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Journal of bacteriology · 2019
    Article
  14. Quantitative Proteome Profiling ofFrontiers in microbiology · 2019
    Article
  15. PromiscuousFrontiers in immunology · 2019
    Article
  16. The Journal of biological chemistry · 2018
    Article
  17. Article
  18. Article
  19. Multiple Substrate Usage ofFrontiers in cellular and infection microbiology · 2017
    Article
  20. The Intervening Sequence of Coxiella burnetii: Characterization and Evolution.Frontiers in cellular and infection microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sherry A ColemanCoxiella Pathogenesis Section, Research Technology Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Elizabeth R Fischer
Diane C Cockrell
Daniel E Voth
Dale Howe
David J Mead
James E Samuel
Robert A Heinzen

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Cellular and Developmental Biology of Coxiella burnetiiZ01AI000931 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HEINZEN, ROBERT A · 2003 to 2008
$2.2M
Intramural NIH HHSNIAID NIH HHS AI057156NIAID NIH HHS U54 AI057156
6 · The paper itself

Abstract

A biphasic developmental cycle whereby highly resistant small-cell variants (SCVs) are generated from large-cell variants (LCVs) is considered fundamental to the virulence of Coxiella burnetii, the causative agent of human Q fever. In this study a proteome analysis of C. burnetii developmental forms was conducted to provide insight into their unique biological and immunological properties. Silver-stained gels of SCV and LCV lysates separated by two-dimensional (2-D) gel electrophoresis resolved over 675 proteins in both developmental forms. Forty-eight proteins were greater than twofold more abundant in LCVs than in SCVs, with six proteins greater than twofold more abundant in SCVs than in LCVs. Four and 15 upregulated proteins of SCVs and LCVs, respectively, were identified by mass spectrometry, and their predicted functional roles are consistent with a metabolically active LCV and a structurally resistant SCV. One-dimensional and 2-D immunoblots of cell form lysates probed with sera from infected/vaccinated guinea pigs and convalescent-phase serum from human patients who had recovered from acute Q fever, respectively, revealed both unique SCV/LCV antigens and common SCV/LCV antigens that were often differentially synthesized. Antigens recognized during human infection were identified by mass spectroscopy and included both previously described immunodominant proteins of C. burnetii and novel immunogenic proteins that may be important in the pathophysiology of clinical Q fever and/or the induction of protective immunity.

Indexed as

AnimalsAntigens, BacterialBacterial ProteinsComet AssayCoxiella burnetiiElectrophoresis, Gel, Two-DimensionalGuinea PigsHumansImmunoblottingImmunodominant EpitopesMass SpectrometryMicroscopy, Electron, TransmissionProteomeAntigens, BacterialBacterial ProteinsImmunodominant EpitopesProteome

Identifiers

PMID17088354
PMCPMC1828411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.